Management of Persistent Skin Rash and Itching While Taking Atarax (Hydroxyzine)
Stop Atarax immediately—this is likely a paradoxical hypersensitivity reaction to hydroxyzine itself, which, though rare, is well-documented and will worsen with continued use.
Understanding the Problem
Hydroxyzine (Atarax) is an antihistamine prescribed to treat itching and rash, but in rare cases, it can paradoxically cause these symptoms through hypersensitivity reactions. This creates a diagnostic challenge because the medication's side effects mimic the condition being treated 1, 2, 3.
Key Clinical Features of Hydroxyzine Hypersensitivity:
- Presentation: Maculopapular eruptions, generalized urticaria, or worsening of pre-existing dermatitis 3, 4
- Timing: Can occur rapidly (within hours to days) after initial or continued dosing 3
- Mechanism: Often related to cross-reactivity with ethylenediamine (a structural component) 1, 5, 4
- Pattern: Symptoms paradoxically worsen despite taking an "anti-itch" medication 1, 3
Immediate Management Algorithm
Step 1: Discontinue Hydroxyzine
- Stop the medication immediately 1, 3, 5
- Do not attempt dose reduction—complete cessation is required
- Document the reaction for future medication records
Step 2: Assess Severity and Treat Symptomatically
For Mild-to-Moderate Rash (<30% body surface area):
- Switch to a non-sedating H1 antihistamine that is structurally different 6:
- Cetirizine 10 mg daily OR
- Loratadine 10 mg daily OR
- Fexofenadine 180 mg daily
- Apply topical corticosteroids 7:
- High-potency (Class I): Clobetasol propionate 0.05% for body
- Low-potency (Class V-VI): Hydrocortisone 2.5% for face
- Use emollients with fragrance-free, cream-based products 7
For Moderate-to-Severe Rash (>30% body surface area or limiting daily activities):
- Urgent dermatology referral 7
- Oral corticosteroids: Prednisone 0.5-1 mg/kg/day, tapered over 2-4 weeks 7
- Rule out systemic hypersensitivity with CBC, comprehensive metabolic panel 7
- Continue topical treatments as above
Step 3: Avoid Cross-Reactive Medications
Do NOT use these alternatives (risk of cross-reactivity):
- Cetirizine (metabolite of hydroxyzine) 6, 4
- Other ethylenediamine-containing compounds 1, 5, 4
- Topical antihistamines (high sensitization risk) 2
Safe alternatives include:
- Loratadine, desloratadine, fexofenadine, or levocetirizine 6
- These have different chemical structures and minimal cross-reactivity
Important Clinical Pitfalls
Common Diagnostic Error
Physicians often increase the hydroxyzine dose or add additional antihistamines when symptoms worsen, not recognizing that hydroxyzine itself is the culprit 1, 3. This makes the reaction worse.
The "Ethylenediamine Connection"
Hydroxyzine contains an ethylenediamine moiety. Patients sensitized to ethylenediamine (found in some topical preparations, industrial exposures) are at higher risk 1, 5. Consider patch testing to ethylenediamine if the diagnosis is uncertain 1, 3.
Cetirizine Cross-Reactivity
Since cetirizine is the active metabolite of hydroxyzine, patients with hydroxyzine hypersensitivity frequently react to cetirizine as well 6, 4. Avoid this substitution.
Long-Term Considerations
If Symptoms Persist After Stopping Hydroxyzine:
- Continue non-sedating antihistamines at standard or increased doses (up to 4x licensed dose if needed) 6
- Consider adding H2-antihistamines (ranitidine, famotidine) for additional benefit 6
- For severe pruritus: Add gabapentin 100-300 mg three times daily 7
Documentation for Future Care:
- Document hydroxyzine allergy in medical records 2
- Note potential cross-reactivity with cetirizine and ethylenediamine
- Provide patient with written documentation of the reaction
Special Populations
Renal Impairment: If switching to alternative antihistamines, dose adjustments are needed 6:
- Cetirizine/levocetirizine: Halve the dose in moderate renal impairment
- Loratadine/desloratadine: Use with caution in severe impairment
Hepatic Impairment: Avoid hydroxyzine entirely in severe liver disease due to inappropriate sedating effects 6
Evidence Quality Note
While hydroxyzine hypersensitivity is well-documented in case reports and series 1, 2, 3, 5, 4, large-scale studies are lacking because the reaction is rare. However, the consistent pattern across multiple reports—worsening dermatitis with hydroxyzine use that resolves upon discontinuation—provides strong clinical evidence for this phenomenon. The 2007 British Journal of Dermatology urticaria guidelines 6 support using non-sedating antihistamines as first-line therapy, with sedating antihistamines like hydroxyzine reserved only for nighttime use in select cases, not as primary therapy.